PNR:NYSEPentair plc. Analysis
Data as of 2026-05-21 - not real-time
$74.19
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Pentair plc (PNR) is trading at $74.19, well below its 20‑day SMA of $79.02 and 50‑day SMA of $84.65, signaling a bearish technical backdrop. The 14‑day RSI of 35 points to oversold conditions, yet the MACD histogram remains negative and volume is decreasing, reinforcing short‑term downside pressure. Volatility is elevated at over 40% and beta exceeds 1.1, indicating heightened price swings relative to the market.
Fundamentally, the company posts solid margins (gross 41%, operating 23%) and a healthy ROE of 17.6%, while the forward PE of 12.8 is well below the industry average PE of 29.5, suggesting relative cheapness. However, the DCF‑derived fair value of $38.55 is far lower than the current price, and a debt‑to‑equity ratio of 54.6% raises leverage concerns. The dividend yield of 1.43% is sustainable given a 25% payout ratio and strong operating cash flow. Analyst consensus remains bullish with a median target of $106, implying upside potential if the stock can reverse its technical weakness.
Fundamentally, the company posts solid margins (gross 41%, operating 23%) and a healthy ROE of 17.6%, while the forward PE of 12.8 is well below the industry average PE of 29.5, suggesting relative cheapness. However, the DCF‑derived fair value of $38.55 is far lower than the current price, and a debt‑to‑equity ratio of 54.6% raises leverage concerns. The dividend yield of 1.43% is sustainable given a 25% payout ratio and strong operating cash flow. Analyst consensus remains bullish with a median target of $106, implying upside potential if the stock can reverse its technical weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and decreasing volume
- Price below short‑term moving averages
- High 30‑day volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE of 12.8 versus industry PE of 29.5
- Projected earnings growth (forward EPS $5.82)
- Analyst median price target of $106
Long Term
> 3 yearsNeutral
Model confidence: 8/10
Key Factors
- Consistent cash generation and sustainable dividend
- Strong ROE and operating margins
- Elevated leverage requiring monitoring
Key Metrics & Analysis
Financial Health
Revenue Growth2.60%
Profit Margin15.97%
P/E Ratio18.6
ROE17.61%
ROA8.88%
Debt/Equity54.63
P/B Ratio3.1
Op. Cash Flow$786.3M
Free Cash Flow$574.2M
Industry P/E29.5
Technical Analysis
TrendBearish
RSI35.3
Support$70.73
Resistance$94.17
MA 20$79.02
MA 50$84.65
MA 200$100.26
MACDBearish
VolumeDecreasing
Fear & Greed Index90.3
Valuation
Fair Value$38.55
Target Price$102.32
Upside/Downside37.91%
GradeFair
TypeBlend
Dividend Yield1.43%
Risk Assessment
Beta1.20
Volatility40.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.